Advanced Solid Tumors With Kras G12c Mutation clinical trials

Explore recruiting advanced solid tumors with kras g12c mutation clinical trials.

Recruiting advanced solid tumors with kras g12c mutation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Solid Tumors With Kras G12c Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-21822 Monotherapy and Combination Therapy in Adult Patients with Advanced Solid Tumors Harboring KRAS G12C Mutation

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Advanced Solid Tumors With Kras G12c Mutation trials by city

Advanced Solid Tumors With Kras G12c Mutation in Toronto Advanced Solid Tumors With Kras G12c Mutation in Vancouver Advanced Solid Tumors With Kras G12c Mutation in Montreal Advanced Solid Tumors With Kras G12c Mutation in Calgary Advanced Solid Tumors With Kras G12c Mutation in Edmonton Advanced Solid Tumors With Kras G12c Mutation in Ottawa Advanced Solid Tumors With Kras G12c Mutation in Winnipeg Advanced Solid Tumors With Kras G12c Mutation in Quebec City Advanced Solid Tumors With Kras G12c Mutation in Hamilton Advanced Solid Tumors With Kras G12c Mutation in Kitchener Advanced Solid Tumors With Kras G12c Mutation in London Advanced Solid Tumors With Kras G12c Mutation in Halifax Advanced Solid Tumors With Kras G12c Mutation in New York Advanced Solid Tumors With Kras G12c Mutation in Los Angeles Advanced Solid Tumors With Kras G12c Mutation in Chicago Advanced Solid Tumors With Kras G12c Mutation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease